A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study's abstract, medication administration issues remain a persistent issue in the U.S. Investigators … [Read More...] about Study says smart infusion pump interoperability can enhance medication delivery
Main Content
Drug Tech
Today on Drug Delivery Business
- Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
- Tidepool achieves new certification for open-source quality management system
- Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
- Study says smart infusion pump interoperability can enhance medication delivery
- Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery
- Aptar reports positive adherence results with iPump dose software
- Tidepool founder and CEO is stepping down
Sponsored Content

Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts

Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
By Sean Whooley
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the MiniMed 780G. Approval provides more options for users of the automated insulin delivery (AID) system, which can also work with the … [Read More...] about Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G

Tidepool achieves new certification for open-source quality management system
By Sean Whooley
Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management group, develops open-source technology for the … [Read More...] about Tidepool achieves new certification for open-source quality management system

Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
By Sean Whooley
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe. FORGETDIABETES aims to develop a long-term automated insulin delivery system. This system should enable optimal glucose control … [Read More...] about Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe

Study says smart infusion pump interoperability can enhance medication delivery
By Sean Whooley
A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study's abstract, medication administration issues remain a persistent issue in the U.S. Investigators … [Read More...] about Study says smart infusion pump interoperability can enhance medication delivery

Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery
By Sean Whooley
Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care. The collaboration aims to integrate Nanowear's at-home AI-based nanotechnology biomarker diagnostic platform with … [Read More...] about Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery

Aptar reports positive adherence results with iPump dose software
By Sean Whooley
Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication adherence. The SPEED survey looked at iPump's effect on adherence to Stallergenes Greer’s sublingual liquid immunotherapy … [Read More...] about Aptar reports positive adherence results with iPump dose software

Retractable Technologies cuts workforce as it reduces reliance on China amid trade war
By Sean Whooley
Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, Texas-based maker of products like syringes and needles said the move comes as it allocates more resources to the U.S. It aims … [Read More...] about Retractable Technologies cuts workforce as it reduces reliance on China amid trade war

Dexcom wins FDA nod for 15-day CGM
By Sean Whooley
Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system. The clearance covers people over the age of 18 years old in the U.S. It makes the G7, Dexcom's latest-generation CGM, the … [Read More...] about Dexcom wins FDA nod for 15-day CGM

Doctors issue call to action to eliminate barriers to automated insulin delivery
By Sean Whooley
Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert's Diabetes Technology & Therapeutics, to … [Read More...] about Doctors issue call to action to eliminate barriers to automated insulin delivery

How ICU Medical plans to mitigate tariff impact
By Sean Whooley
Needham analysts report that ICU Medical (Nasdaq: ICUI) has a plan in place to handle its exposure to the tariffs imposed by the Trump Administration. Medtech stocks already took a hit last month as in response to Trump’s tariff policies. … [Read More...] about How ICU Medical plans to mitigate tariff impact
In case you missed it
- Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system
- Medtronic has a new leader in its Diabetes unit
- Insulet launches Omnipod 5 in Canada
- ICU Medical launches new category of infusion pumps
- U-Pump takes next steps with AI-powered insulin patch pump
- Embecta shares study highlighting need for training, standardization in insulin delivery
- Glucotrack expects FDA IDE for implantable CBGM this year
- SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
- Dexcom picks longtime Masimo exec as next CCO
- Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’
- Nanowear enters CGM licensing, data partnership with Dexcom
- Enable Injections wins CE mark for enFuse drug delivery device
- The biggest diabetes tech news out of ATTD 2025
- Beta Bionics founder talks bringing ‘bionic pancreas’ to market
- Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Clinical Trials

Study says smart infusion pump interoperability can enhance medication delivery
A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study’s abstract, medication administration issues remain a persistent issue in the U.S. Investigators believe that smart infusion pump interoperability with electronic health records (EHRs) could potentially reduce IV errors. Smart infusion pumps safely deliver IV medications […]

Aptar reports positive adherence results with iPump dose software
Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication adherence. The SPEED survey looked at iPump’s effect on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT). Stallergenes Greer will present findings at the CFA congress (Congrès Francophone d’Allergologie) in Paris this week. iPump, developed in conjunction with […]

The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]

Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic’s Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor (CGM). Data showed how the system, designed for people with diabetes using multiple daily injections (MDI) when used as intended, […]

Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Insulet (Nasdaq:PODD) today announced new Omnipod 5 clinical data highlighting the transition from multiple daily injections (MDI). Investigators shared data from the RADIANT study at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. The randomized controlled trial evaluated the direct transition from MDI to automated insulin delivery (AID). Insulet […]